Predictors of excellent response to lithium: results from a nationwide register-based study
The DOI matches its Crossref record.
Abstract
The aim of this study was to identify sociodemographic and clinical predictors of excellent response, that is, 'cure' of future affective episodes, to lithium in monotherapy. We used nationwide registers to identify all patients with a diagnosis of bipolar disorder in psychiatric hospital settings who were prescribed lithium from 1995 to 2006 in Denmark (N=3762). Excellent lithium responders were defined as patients who after a stabilization lithium start-up period of 6 months, continued lithium in monotherapy without getting hospitalized. The rate of excellent response to lithium in monotherapy was 8.9% [95% confidence interval (CI): 7.9-9.9] at 5-year follow-up and 5.4% (95% CI: 4.4-6.3) at 10-year follow-up. The rate of nonresponse to lithium monotherapy was significantly increased for female patients [hazards ratio (HR)=1.12, 95% CI: 1.04-1.21) and for patients with a depressive index episode compared with patients in remission or with a diagnosis of other or unspecified bipolar disorder before first lithium purchase (HR=1.13, 95% CI: 1.03-1.25). The rate of nonresponse increased by 3% (95% CI: 2-5%) for every psychiatric hospitalization before first purchase of lithium. Patients with somatic comorbidity had increased rates of non-response to lithium compared with patients without somatic comorbidity (HR=1.23, 95% CI: 1.00-1.52).It is concluded that the prevalence of excellent response to lithium monotherapy is low and such patients are characterized by few earlier psychiatric hospitalizations, a manic index episode before lithium and reduced somatic comorbidity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Useful data can be obtained from large, often whole‐population databases constructed from electronic medical records or electronic patient registries with large numbers of patients that would be difficult to obtain in RCTs. In some instances, they allow comparisons of multiple treatments.358, 359, 360”
In the citing paper
“Some,359, 401, 402 but not all,403, 404 reports suggest that long‐term treatment becomes less effective with longer duration of untreated illness,”
Citations
Cites
Still being checked.
Cited by
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12609 · Cited by 1,852
“As well, two meta-analysis have concluded that divalproex is effective in preventing relapse of mood episodes (370, 372), and a population based cohort study in the UK showed that there were no differences in efficacy between divalproex, quetiapine and olanzapine in the maintenance treatment of bipolar disorder (359).”
Kessing, L. V., Hansen, H. V., Hvenegaard, A., Christensen, E. M., Dam, H., Gluud, C., Wetterslev, J., & The Early Intervention Affective Disorders (EIA) Trial Group (2013) · British Journal of Psychiatry · doi:10.1192/bjp.bp.112.113548 · Cited by 219
Self-citationAreas of controversy in neuroprogression in bipolar disorder
Passos, I. C., Mwangi, B., Vieta, E., Berk, M., & Kapczinski, F. (2016) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12581 · Cited by 208
A systematic review and meta‐analysis of clinical predictors of lithium response in bipolar disorder
Hui, T. P., Kandola, A., Shen, L., Lewis, G., Osborn, D. P. J., Geddes, J. R., & Hayes, J. F. (2019) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13062 · Cited by 138
Neurobiological correlates of illness progression in the recurrent affective disorders
Post, R. M., Fleming, J., & Kapczinski, F. P. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.02.004 · Cited by 159
Areas of uncertainties and unmet needs in bipolar disorders: clinical and research perspectives
Bauer, M., Andreassen, O. A., Geddes, J. R., Kessing, L. V., Lewitzka, U., Schulze, T. G., & Vieta, E. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(18)30253-0 · Cited by 157
Self-citationNationwide and population‐based prescription patterns in bipolar disorder
Kessing, L. V., Vradi, E., & Andersen, P. K. (2016) · Bipolar Disorders · doi:10.1111/bdi.12371 · Cited by 134
Self-citationStarting lithium prophylaxis early v.late in bipolar disorder
Kessing, L. V., Vradi, E., & Andersen, P. K. (2014) · British Journal of Psychiatry · doi:10.1192/bjp.bp.113.142802 · Cited by 101
Self-citationAmare, A. T., Schubert, K. O., Hou, L., Clark, S. R., Papiol, S., Cearns, M., Heilbronner, U., Degenhardt, F., Ayele, F. T., Hsu, Y., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0689-5 · Cited by 102
Prediction of lithium response using clinical data
Nunes, A., Ardau, R., Berghöfer, A., Bocchetta, A., Chillotti, C., Deiana, V., Garnham, J. S., Grof, E., Hájek, T., Manchia, M., et al. (2019) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13122 · Cited by 95
Personalized medicine in psychiatry
Wium-Andersen, I. K., Vinberg, M., Kessing, L. V., & McIntyre, R. S. (2017) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2016.1216163 · Cited by 74
Self-citationClinical factors associated with lithium response in bipolar disorders
Sportiche, S., Geoffroy, P. A., Brichant‐Petitjean, C., Gard, S., Khan, J.-P., Azorin, J., Henry, C., Leboyer, M., Étain, B., Scott, J. L., et al. (2016) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867416664794 · Cited by 72
Changes in the corpus callosum in women with late-stage bipolar disorder
Lavagnino, L., Cao, B., Mwangi, B., Wu, M.-J., Sanches, M., Zunta-Soares, G. B., Kapczinski, F., & Soares, J. (2015) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12397 · Cited by 64
Lithium for bipolar disorder: a review of the recent literature
Curran, G., & Ravindran, A. V. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.947965 · Cited by 67
Etain, B., Lajnef, M., Brichant‐Petitjean, C., Geoffroy, P. A., Henry, C., Gard, S., Kahn, J. P., Leboyer, M., Young, A. H., & Bellivier, F. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12684 · Cited by 62
Schubert, K. O., Thalamuthu, A., Amare, A. T., Frank, J., Streit, F., Adl, M., Akula, N., Akiyama, K., Ardau, R., Arias, B., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01702-2 · Cited by 65
Machado‐Vieira, R. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.12.026 · Cited by 75
New Advances in the Pharmacology and Toxicology of Lithium: A Neurobiologically Oriented Overview
Bortolozzi, A. A., Fico, G., Berk, M., Solmi, M., Fornaro, M., Quevedo, J., Zarate, C. A., Kessing, L. V., Vieta, E., & Carvalho, A. F. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000007 · Cited by 73
Self-citationRisk of recurrence after a single manic or mixed episode – a systematic review and meta‐analysis
Kessing, L. V., Andersen, P. K., & Vinberg, M. (2017) · Bipolar Disorders · doi:10.1111/bdi.12593 · Cited by 43
Self-citationRefractory bipolar disorder and neuroprogression
da Costa, S. C., Passos, I. C., Lowri, C., Soares, J. C., & Kapczinski, F. P. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.09.005 · Cited by 39
Aims and structure of the German Research Consortium BipoLife for the study of bipolar disorder
Ritter, P. S., Bermpohl, F., Gruber, O., Hautzinger, M., Jansen, A., Juckel, G., Kircher, T. T. J., Lambert, M., Mulert, C., Pfennig, A., et al. (2016) · International Journal of Bipolar Disorders · doi:10.1186/s40345-016-0066-0 · Cited by 40
On behalf of the ISBD-IGSLI Joint Task Force on Lithium Treatment, Laroche, D. G., Étain, B., Severus, E., Scott, J. L., & Bellivier, F. (2020) · International Journal of Bipolar Disorders · doi:10.1186/s40345-020-00203-3 · Cited by 35
Epidemiology of mood disorders
Kessing, L. V. (2020) · doi:10.1093/med/9780198713005.003.0067 · Cited by 33
Self-citationScott, J. L., Geoffroy, P. A., Sportiche, S., Brichant‐Petitjean, C., Gard, S., Kahn, J., Azorin, J., Henry, C., Étain, B., & Bellivier, F. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.08.069 · Cited by 32
Towards the clinical implementation of pharmacogenetics in bipolar disorder
Salloum, N. C., McCarthy, M. J., Leckband, S. G., & Kelsoe, J. R. (2014) · BMC Medicine · doi:10.1186/1741-7015-12-90 · Cited by 34
The Link between Refractoriness and Neuroprogression in Treatment-Resistant Bipolar Disorder
Bauer, I. E., Soares, J. C., Selek, S., & Meyer, T. D. (2017) · Modern trends in psychiatry · doi:10.1159/000470803 · Cited by 29
Can network analysis shed light on predictors of lithium response in bipolar I disorder?
Scott, J. L., Bellivier, F., Manchia, M., Schulze, T. G., Alda, M., & Étain, B. (2020) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13163 · Cited by 28
Early improvement with lithium in classic mania and its association with later response
Machado‐Vieira, R., Luckenbaugh, D. A., Soeiro‐de‐Souza, M. G., Marca, G., Henter, I. D., Busnello, J. V., Gattaz, W. F., & Zarate, C. A. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.05.039 · Cited by 25
Pharmacogenomics of Lithium Response in Bipolar Disorder
Vecera, C. M., Fries, G. R., Shahani, L., Soares, J. C., & Machado‐Vieira, R. (2021) · Pharmaceuticals · doi:10.3390/ph14040287 · Cited by 23
Genetics of Lithium Response in Bipolar Disorder
Papiol, S., Schulze, T. G., & Alda, M. (2018) · Pharmacopsychiatry · doi:10.1055/a-0590-4992 · Cited by 20
Genetic and Epigenetic Markers of Lithium Response
Pisanu, C., Meloni, A., Severino, G., & Squassina, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031555 · Cited by 19
Methylomic biomarkers of lithium response in bipolar disorder: a clinical utility study
Marie-Claire, C., Courtin, C., Bellivier, F., Gard, S., Leboyer, M., Scott, J. L., & Étain, B. (2023) · International Journal of Bipolar Disorders · doi:10.1186/s40345-023-00296-6 · Cited by 19
Methylomic Biomarkers of Lithium Response in Bipolar Disorder: A Proof of Transferability Study
Marie-Claire, C., Courtin, C., Bellivier, F., Scott, J. L., & Étain, B. (2022) · Pharmaceuticals · doi:10.3390/ph15020133 · Cited by 16
Recommendations for defining treatment outcomes in major psychiatric disorders using real-world data
Koch, E. M., Smart, S. E., Einarsson, G., Kämpe, A. J., Jönsson, L., Alver, M., Iveson, M. H., Göteson, A., Pardiñas, A. F., Sønderby, I. E., et al. (2025) · The Lancet Psychiatry · doi:10.1016/s2215-0366(25)00061-6 · Cited by 17
Montlahuc, C., Curis, E., Laroche, D. G., Bagoe, G., Étain, B., Bellivier, F., & Chevret, S. (2018) · Pharmacopsychiatry · doi:10.1055/s-0044-100521 · Cited by 13
Goldberg, J. F. (2019) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20190005 · Cited by 12
Ragazan, D. C., Eberhard, J., & Berge, J. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.598946 · Cited by 9
Scheen, L., Brandt, L., Bodén, R., Tiihonen, J., Andersen, M. T., Kieler, H., & Reutfors, J. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.09.044 · Cited by 9
Post, R. M., Altshuler, L. L., Leverich, G. S., Nolen, W. A., Kupka, R., Grunze, H., Frye, M. A., Suppes, T. M., McElroy, S. L., Keck, P. E., et al. (2014) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.14m01677 · Cited by 9
Clinical response and metabolic effects of lithium in 323 mood disorder patients
Pinna, M., Manchia, M., Visioli, C., & Tondo, L. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.03.066 · Cited by 7
Treatment Options in Bipolar Disorder: Lessons from Population-Based Registers with Focus on Lithium
Kessing, L. V. (2015) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-015-0047-4 · Cited by 5
Self-citationKessing, L. V., Ziersen, S. C., Budtz–Jørgensen, E., & Gerds, T. A. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.11.046 · Cited by 5
Self-citationKessing, L. V., Ziersen, S. C., Gerds, T. A., & Budtz–Jørgensen, E. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.04.098 · Cited by 5
Self-citationMeta-analysis of recurrence rate and influencing factors of bipolar disorder
Bai, C., Fan, X., Lu, W., Wei, M., & Wu, D. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.120570 · Cited by 6
Ulusoy, M., Başkak, B., Çakmak, I. B., Tok, K. C., & Suzen, H. S. (2025) · Chronobiology International · doi:10.1080/07420528.2025.2597961 · Cited by 3
Elevated choline in dorsolateral prefrontal cortex of lithium responders with bipolar I disorder
Mahal, P., Deep, R., Kumaran, S. S., & Khandelwal, S. K. (2022) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2022.103318 · Cited by 2
El‐Mallakh, R. S., Roberts, R. J., & Gao, Y. (2014) · Side effects of drugs annual · doi:10.1016/b978-0-444-62635-6.00003-6 · Cited by 2
Amare, A. T., Schubert, K. O., Hou, L., Clark, S. R., Papiol, S., Cearns, M., Heilbronner, U., Degenhardt, F., Ayele, F. T., Hsu, Y., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/449363 · Cited by 2
McQuillin, A., Yao, K., Nadeem, A., van der Veen, T., Thygesen, J. H., Jönsson, L., Landén, M., Song, J., & Bass, N. J. (2024) · Research Square · doi:10.21203/rs.3.rs-4000581/v1 · Cited by 2
Actualización en el uso y el manejo del litio en neuropsiquiatría
Corrales, A., Cetkovich, M., Abadi, A. F., Camino, S., Bonetto, G. G., Mato, A. M. L., Marengo, E., Abraham, E., Maresca, T., Bagnati, P. R. A. D. N., et al. (2024) · Vertex Revista Argentina de Psiquiatría · doi:10.53680/vertex.v34i162.504 · Cited by 2
A physical perspective on lithium therapy
Kamp, D. (2024) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2024.11.002 · Cited by 5
Lityuma Tedavi Yanıtının Klinik, Biyolojik ve Genetik Yordayıcıları
Bozkurt, H. T., Erbasan, V., Eğilmez, Ü., Şen, B., Aydın, M., & Altınbaş, K. (2018) · Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry · doi:10.18863/pgy.347570 · Cited by 2
Evidence-Based Principles for Bipolar Disorder Treatment
(2019) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.17303
Kessing, L. V., & Andersen, P. K. (2014) · The British Journal of Psychiatry · doi:10.1192/bjp.205.5.411a
Self-citationLiving in a Pharmacologically Imperfect World
Goldberg, J. F. (2022) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.22ed14665
Meyer, J. M., & Stahl, S. M. (2023) · Cambridge University Press eBooks · doi:10.1017/9781009225069.004
Avinash, P., Pathak, K., Saxena, V., Singh, V., & Mehta, S. (2024) · Annals of Indian Psychiatry · doi:10.4103/aip.aip_136_23
Laroche, D. G., Étain, B., Severus, E., Scott, J. L., & Bellivier, F. (2020) · Figshare · doi:10.6084/m9.figshare.13467619
Marie-Claire, C., Courtin, C., Bellivier, F., Gard, S., Leboyer, M., Scott, J. L., & Étain, B. (2024) · Figshare · doi:10.6084/m9.figshare.26585925
Marie-Claire, C., Courtin, C., Bellivier, F., Gard, S., Leboyer, M., Scott, J. L., & Étain, B. (2024) · Figshare · doi:10.6084/m9.figshare.26585922
Laroche, D. G., Étain, B., Severus, E., Scott, J. L., & Bellivier, F. (2020) · Figshare · doi:10.6084/m9.figshare.13467611
Laroche, D. G., Étain, B., Severus, E., Scott, J. L., & Bellivier, F. (2020) · Figshare · doi:10.6084/m9.figshare.13467613
Laroche, D. G., Étain, B., Severus, E., Scott, J. L., & Bellivier, F. (2020) · Figshare · doi:10.6084/m9.figshare.13467609
Epidemiology of Bipolar Disorder
Kessing, L. V. (2025) · Springer eBooks · doi:10.1007/978-3-032-01297-5_2 · Cited by 2
Self-citationNylander, P., Lexne, E., Lehman, C., Brudin, L. H., & Bengtsson, F. (2026) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2026.100791
Betelli, D., Furno, S., Bravi, B., Carlo, C. D., Lorenzi, C., Spadini, S., Finardi, A., Colombo, C., Furlan, R., Poletti, S., et al. (2026) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000637
Momen, N. C., Liu, X., Kohler-Forsberg, O., Bech, B. H., & Plana‐Ripoll, O. (2026) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.70145
Metadata
- Authors
- Kessing, L. V., Hellmund, G., & Andersen, P. K.
- Affiliations
- Copenhagen University Hospital (DK)
- University of Copenhagen (DK)
- Corresponding author
- Kessing, Lars Vedel
- Venue
- International Clinical Psychopharmacology
- Published
- 2011-11
- Volume
- 26
- Issue
- 6
- Pages
- 323-328
- ISSN
- 0268-1315 (ISSN-L)
- OpenAlex
- W2320600621
- Cited by
- 68
- References
- 0
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 7 · 2023: 2 · 2022: 5 · 2021: 3 · 2020: 10 · 2019: 4 · 2018: 7 · 2017: 3 · 2016: 7 · 2015: 3 · 2014: 7 · 2013: 1 · 2012: 2
- FWCI
- 2.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- International Clinical Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Funders
- Bristol-Myers Squibb
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- lithium, bipolar disorder, lithium monotherapy, predictors of treatment response, psychiatric hospitalization, somatic comorbidity, depressive episodes, manic episodes, sex differences, psychiatric inpatients
- MeSH terms
- Adult, Bipolar Disorder, Denmark, Depressive Disorder, Female, Follow-Up Studies, Hospitals, Psychiatric, Humans, Longitudinal Studies, Male, Middle Aged, Recurrence, Registries, Comorbidity, Treatment Outcome, Treatment Failure, Lithium Compounds, Disease Progression, Antimanic Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.